LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients

Clinical trial NCT04728932 · COMPLETED

Trial details

NCT number: NCT04728932
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiogenic Shock Extracorporeal Membrane Oxygenation Complication

Start date: 2021-08-27
Primary completion: 2024-11-09
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.